[Elsevier] Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response

Boqun Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-31 17:30
Reward10points

journalㄩMetabolism

AuthorsㄩGuo-Qiang Pan; Yu-Chuan Yan; Rui-Zhe Li; Chen Xiong; Shao-peng Zhang; Ying Qu; Rui Dong; Yu Zhou; Tuan-Song Zhang; Zhi-Qiang Chen; Xiao-Lu Zhang; Xiao-Feng Dong; Dong-Xu Wang; Zhao-Ru Dong; Tao Li

Published dateㄩ2025-9-

DOIㄩ10.1016/j.metabol.2025.156304

PDF linkㄩhttps://www.sciencedirect.com/sc ... 026049525001738/pdf

Article linkㄩhttps://doi.org/10.1016/j.metabol.2025.156304

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    40


Return to the list